Models & Releases

Sequoia, YC, A16Z Back 158 AI Startups With Record Funding in 2026

From healthcare to cybersecurity, top VCs are pouring billions into AI-native startups.

Deep Dive

A comprehensive tracker of 158 AI startups funded by elite investors—Sequoia, Y Combinator, Andreessen Horowitz, Accel, Khosla Ventures, and more—highlights the explosive growth in AI investment heading into 2026. The startups span diverse verticals: healthcare AI (Ambience Healthcare at $243M, Blossom at $20M for psychiatry agents), cybersecurity (Doppel at $70M for impersonation defense), enterprise tools (Omnea at $50M for procurement, Encord at $60M for multimodal data), and frontier tech (Harmonic at $100M for mathematical superintelligence). Many companies are at Series A or B, indicating early-stage confidence from top-tier VCs.

Key trends include the rise of AI agents (Avoca for service businesses, Traba for supply chain), medical document automation (Tennr at $101M), and autonomous research (Listen Labs at $27M). Investors are backing niche applications as well as platform plays, with funding concentrated in San Francisco, New York, and London. This dataset underscores a pivotal shift: AI is no longer a single category but an infrastructure layer across every industry, from psychiatry to supply chains. The sheer volume of capital—with rounds exceeding $100M becoming common—signals that 2026 will be a defining year for AI-native startups scaling into real-world deployment.

Key Points
  • 158 AI startups funded by Sequoia, YC, A16Z, Accel, and Khosla Ventures across 15+ industries.
  • Largest rounds: Ambience Healthcare ($243M, clinical AI), Harmonic ($100M, mathematical AI), Tennr ($101M, medical document automation).
  • Key sectors: healthcare (4+ startups), cybersecurity (Doppel), enterprise software (Encord, Omnea), and supply chain (Traba).

Why It Matters

Top VCs are heavily betting that AI will transform every industry, from healthcare to supply chains, with record early-stage funding.